Patent · US Active

Compounds for the treatment of inflammatory disorders

US7687527B2 · kind B2 · utility

6Cited by

7References

9Claims

0Family size

Assignee

SCHERING CORPORATION · US

Inventors

Wensheng Yu · Edison, US
Ling Tong · Hackettstown, US
Lei Chen · Singapore, SG
Joseph A. Kozlowski · Princeton, US
Brian J. Lavey · New Providence, US
Neng-Yang Shih · Lexington, US
Vincent S. Madison · Mountain Lakes, US
Guowei Zhou · Somerville, US
Peter Orth · New York, US
Zhuyan Guo · Scotch Plains, US
Michael K. C. Wong · New Brunswick, US
De-Yi Yang · Morristown, US
Seong Heon Kim · Livingston, US
Bandarpalle B. Shankar · Readington, US
M. Arshad Siddiqui · Newton, US
Kristin E. Rosner · Watertown, US
Chaoyang Dai · Acton, US
Umar Faruk Mansoor · Framingham, US
Janeta Popovici-Muller · Windham, US
Vinay M. Girijavallabhan · Woburn, US
Dansu Li · New York, US

Key dates

Filing date	Dec 18, 2008
Grant date	Mar 30, 2010
Priority date	—
Expiry date	Dec 18, 2028

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to compounds of the Formula (I):

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.